YODELEZ & SONS LIMITED

Financial Health Score: D- (Comatose but Stable)

This grade reflects a business that is technically alive but exhibits zero financial vitality. The company is not experiencing symptoms of financial distress (such as insurmountable debt), but only because it is entirely inactive. It is a dormant shell with negligible financial mass.

1. Key Vital Signs

• Heartbeat (Trading Activity): Flatline. The latest filed accounts explicitly confirm the company is dormant and has claimed exemption under section 480 of the Companies Act 2006. There is no pulse in terms of revenue, trading, or operational cash flow.
• Blood Pressure (Cash & Liquidity): Dangerously low. In recent years, the cash balance dropped to £0, with total net assets sitting at a mere £2. This consists entirely of unpaid share capital, meaning there is no liquid cash in the business bank account to respond to any unexpected expenses.
• Weight (Total Assets): Severe atrophy. In 2018, the business had total assets of £3,475. Today, it has shed almost all of that mass, weighing in at just £2. The business has no physical or financial reserves to draw upon.
• Cholesterol (Liabilities): Clear. Because the company is dormant, it carries no current or long-term liabilities. While this means the company is not suffering from the "high blood pressure" of debt, it is a byproduct of having no operations rather than good financial management.

2. Diagnosis

Diagnosis: Persistent Financial Vegetative State

The patient is alive but in a deep, prolonged financial coma. Yodelez & Sons Limited was incorporated in 2017 with the apparent intent of operating a removal services business (SIC code 49420). There was a brief flicker of life in 2018 when the balance sheet showed a few thousand pounds in assets and some minor liabilities, suggesting initial capitalization or a very small volume of activity.

However, since 2019, the business has shed all operational mass. The net assets dropped from £3,155 down to £100, and eventually to £2, where they have remained static for the last three years. The most recent accounts even tag the company with uk-bus:EntityHasNeverTraded, which suggests the 2018 activity may have been limited to initial setup costs or director loans that have since been repaid or written off.

Currently, the business has no revenue, no cash, and no operational infrastructure. It exists merely as a legal entity on the Companies House register rather than a functioning enterprise.

3. Recommendations

To improve the financial wellness of this entity, the directors must make a decisive choice about its future. Prolonging this dormant state indefinitely is the equivalent of keeping a patient on life support with no plan for recovery.

1. Decide on the Course of Treatment: The director (Mr. Gabriel Ayodele) must decide if this company still serves a purpose. If there is no intention to operate a removals business, it is time to withdraw life support.
2. Withdraw Life Support (Voluntary Strike-Off): If the company is no longer needed, the most cost-effective and administratively clean solution is to apply for voluntary dissolution. This will remove the requirement to file annual dormant accounts and confirmation statements, saving time and any potential future filing penalties.
3. Resuscitation (Capital Injection): If there is a genuine intention to resuscitate the business and enter the highly competitive London removals market, the business will require an immediate and significant blood transfusion in the form of a capital injection. A removals business requires vehicles, insurance, and marketing capital—none of which can be funded by £2 of unpaid share capital.
4. Review Medical History (Compliance Check): The recent accounts claim the entity has "never traded," yet the 2018 financial history shows £3,475 in assets and £320 in liabilities. While this may be perfectly explainable (e.g., setup costs or temporary director loans), it is vital to ensure that all historical tax and filing obligations were properly settled before the company went dormant, to prevent any latent regulatory infections from surfacing later.